TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID manufacturers
|
| TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID Basic information |
| TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID Chemical Properties |
Melting point | ~255 °C (dec.) | Boiling point | 261.28°C (rough estimate) | density | 1.1095 (rough estimate) | refractive index | 1.4150 (estimate) | pka | 3.77±0.28(Predicted) | form | Powder and Chunks | color | White to almost white | BRN | 3196018 |
Hazard Codes | Xi | Risk Statements | 36/37/38 | Safety Statements | 22-24/25 | WGK Germany | 3 | HS Code | 29224985 |
| TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID Usage And Synthesis |
Chemical Properties | WHITE TO ALMOST WHITE POWDER AND CHUNKS | Uses | peptide synthesis | reaction suitability | reaction type: solution phase peptide synthesis |
| TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID Preparation Products And Raw materials |
|
Tag:TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID(5691-19-0)
Related Product Information
|
ETHYL TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLATE HYDROCHLORIDE
BOC-1,2-TRANS-ACHC-OH
TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID
(1R,2R)-FMOC-2-AMINOCYCLOHEXANE CARBOXYLIC ACID
(1R,2R)-2-AMINO-CYCLOHEXANECARBOXYLIC ACID ETHYL ESTER
(1R,2R)-BOC-2-AMINOCYCLOHEXANE CARBOXYLIC ACID
(1R,2R)-2-(ANTHRACENE-2,3-DICARBOXIMIDO)CYCLOHEXANECARBOXYLIC ACID
(1R,2R)-2-AMINOCYCLOHEXANECARBOXYLIC ACID
(1R,2R)-2-(NAPHTHALENE-2,3-DICARBOXIMIDO)CYCLOHEXANECARBOXYLIC ACID
TRANS-2-AMINO-CYCLOHEXANECARBOXYLIC ACID HYDROCHLORIDE
TRANS-2-AMINO-CYCLOHEXANECARBOXYLIC ACID ETHYL ESTER
FMOC-TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID,FMOC-TRANS-BETA-AMINO-ALPHA-CYCLOHEXANECARBOXYLIC ACID
(1R*,2R*,5R*)-2-BENZYLOXYCARBONYLAMINO-5-HYDROXY-CYCLOHEXANECARBOXYLIC ACID
(1R,2R)-2-BENZOYLAMINO-CYCLOHEXANECARBOXYLIC ACID
TRANS-ETHYL-2-ISOCYANO-CYCLOHEXYLCARBOXYLATE
(1R,2R,3R,5R)-ETHYL-2-AMINO-6,6-DIMETHYLBICYCLO[3.1.1]HEPTAN-3-CARBOXYLATE HYDROCHLORIDE
(2R,3R)-3-[(TERT-BUTOXYCARBONYL)AMINO]BICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID
(1R*,2R*,5R*)-(7-OXO-6-OXA-BICYCLO[3.2.1]OCT-2-YL)-CARBAMIC ACID BENZYL ESTER
|